Xi Tan

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum

Cross Sectional

Glycemic Control

Health Insurance

Top Venues

Clinical drug investigation

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Tan, Yuanjie Liang, Cory Gamble, Aaron King
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Boshu Ru, Xi Tan, Yu Liu, Kartik Kannapur, Dheepan Ramanan, Garin Kessler, Dominik Lautsch, Gregory Y H Lip
Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study. JMIR formative research 7 (2023)
Xi Tan, Lingfeng Yang, Kamlesh Khunti F MedSci, Ruya Zhang, Ye Zhang, Swapnil Rajpathak, Miao Yu
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States. Diabetes, obesity & metabolism 23 (10) (2021)
Xi Tan, Lulu K Lee, Stephanie Huynh, Manjiri Pawaskar, Swapnil Rajpathak
Sociodemographic disparities in the management of type 2 diabetes in the United States. Current medical research and opinion 36 (6) (2020)
Rashmi Goyat, Pragya Rai, Jongwha Chang, Charles D Ponte, Xi Tan
Cardiovascular Mortality of Oral Antidiabetic Drugs Approved Before and After the 2008 US FDA Guidance for Industry: A Systemic Review and Meta-Analysis. Clinical drug investigation 38 (6) (2018)